Chronic lymphocytic leukaemia trials in Bulgaria

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

  Where

  Burgas, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora

  Age

  18 years and over

  People

  386 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT05645107 · EU 2022-502193-16-00
• Phase 3Taking people
  A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.

  Where

  Sofia, Sofiya, Stara Zagora

  Age

  18 years and over

  People

  344 worldwide

  Run by

  Ascentage Pharma Group Inc.

  See details and how to joinNCT06319456 · EU 2024-514084-26-00
• Phase 3Taking people
  Global Trial in APG2575 for Patients With CLL/SLL

  Where

  Plovdiv, Sofia, Sofiya, Stara Zagora, Varna

  Age

  18 years to 99 years

  People

  400 worldwide

  Run by

  Ascentage Pharma Group Inc.

  See details and how to joinNCT06104566 · EU 2023-508005-24-00
• Phase 2Taking people
  Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

  Where

  Plovdiv, Vratsa

  Age

  18 years and over

  People

  75 worldwide

  Run by

  AbbVie

  See details and how to joinNCT04895436 · EU 2023-504599-10-00